Itron rises 7.8% after quarterly results beat estimates and profit improves

What happened

Itron (ITRI) rose 7.8% on October 27, 2026, after reporting third-quarter results that beat estimates and showed improved profitability, driven by revenue at the top of its outlook and record adjusted EBITDA. The stock closed at $94.55, with trading volume 2.0 times its 20-day average. The market was broadly higher: the S&P 500 rose 0.6% and the Technology sector median rose 1.5% on the day.

How big was the move

The session was strong for Itron. The change on the day was 4.0 times a typical daily move for this stock, and its beta of 1.10 indicates the stock tends to move more than the market. Over the last five sessions the stock rose 11.7%, while the S&P 500 over five sessions rose 0.1%. Compared with its sector, the move was 6.3 percentage points better than the sector median on the day.

Similar sessions have been uncommon. In the past five years the stock had 11 sessions with a gain of at least 7.8%. Twenty trading days later the median result was a gain of 6.1%, and 6 of 11 were higher. That historical pattern suggests a modest tendency for further gains after outsized one-day advances, but past patterns are not predictive.

The technical picture

The stock traded above its short- and medium-term averages: 9.6% above its 20-day moving average, 3.6% above its 50-day moving average and 3.9% above its 200-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend. The Relative Strength Index (14 days) was 66, within a neutral range between 30 and 70.

Despite recent strength, the stock remained 33.4% below the 52-week high. Over one month the stock rose 6.8%, over three months it fell 7.6% and over one year it fell 30.4%, leaving it 44.2 percentage points behind the S&P 500. Volatility was 31% annualized over 60 days, lower than 82% of its own readings over five years, indicating recent price moves were relatively less volatile compared with its history.

Fundamentals and valuation

For the four quarters through September 30, 2026 Itron reported revenue of $2.32 billion, a decline of 3.6% from a year earlier and a continuation of recent softness after a revenue decline of 5.7% one quarter earlier. Diluted earnings per share for that period were $6.19, which rose 11.3% from a year earlier. Those diverging trends — weaker revenue but stronger earnings — reflect improving margin performance.

Gross margin improved to 40.7% from 36.3% a year earlier, and operating margin rose to 13.7% from 12.4% a year earlier. Free-cash-flow margin stood at 15.8% and return on invested capital was 7.6%. The balance sheet showed net debt of 1.9 times EBITDA, and the company reduced its share count over one year by 4.8%.

On valuation metrics, the stock traded at 15.3 times trailing earnings, which is lower than 80% of its own readings over the past five years (five-year median: 21.3 times earnings). Price to forward earnings was 14.7 times expected earnings and free-cash-flow yield was 9.6%. PromtFinance scores place Itron high on Value at 95 (Exceptional) and strong on Stability at 83, while Growth and Momentum scored 36 and 41 respectively.

Taken together, the fundamentals show profit margins improving enough to offset modest revenue weakness, producing a cheaper valuation versus the company’s recent history. That combination tends to attract value-oriented investors but may limit enthusiasm from growth-focused funds.

Earnings and analyst expectations

Itron reported last on October 27, 2026, with GAAP diluted EPS of $1.94 against $1.56 expected, 24.4% above estimates. The company said revenue was at the top end of its outlook range and recorded record adjusted EBITDA and improved profitability, according to GlobeNewsWire and Seeking Alpha. The report marked the 15th consecutive quarter in which the company beat estimates, and the average surprise over the last four reports was 19.5% above estimates.

Typical two-day reactions after recent reports saw the stock rise 2.2%. Analysts’ consensus price target was $134.75, 42.5% above the closing price, based on 37 analysts with a consensus rating of Hold and 41% assigning Buy or Strong Buy. The combination of a below-average historical valuation and a consensus target well above the market price highlights differing views between short-term market pricing and analyst expectations.

What to watch

• October 29, 2026: the next report date listed in the earnings schedule.
• Last report on October 27, 2026: GAAP diluted EPS of $1.94 against $1.56 expected, 24.4% above estimates.
• Consensus price target of $134.75, 42.5% above the closing price of $94.55.
• Net debt of 1.9 times EBITDA and free-cash-flow margin of 15.8%.
• PromtFinance Value score 95 (Exceptional) and Revisions score 76 (Positive).